首页> 美国卫生研究院文献>Molecules >Development and Applications of the Copper-Catalyzed Azide-Alkyne Cycloaddition (CuAAC) as a Bioorthogonal Reaction
【2h】

Development and Applications of the Copper-Catalyzed Azide-Alkyne Cycloaddition (CuAAC) as a Bioorthogonal Reaction

机译:铜催化的叠氮化物-炔烃环加成反应(生物正交反应)的开发与应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The emergence of bioorthogonal reactions has greatly broadened the scope of biomolecule labeling and detecting. Of all the bioorthogonal reactions that have been developed, the copper-catalyzed azide-alkyne cycloaddition (CuAAC) is the most widely applied one, mainly because of its relatively fast kinetics and high efficiency. However, the introduction of copper species to in vivo systems raises the issue of potential toxicity. In order to reduce the copper-induced toxicity and further improve the reaction kinetics and efficiency, different strategies have been adopted, including the development of diverse copper chelating ligands to assist the catalytic cycle and the development of chelating azides as reagents. Up to now, the optimization of CuAAC has facilitated its applications in labeling and identifying either specific biomolecule species or on the omics level. Herein, we mainly discuss the efforts in the development of CuAAC to better fit the bioorthogonal reaction criteria and its bioorthogonal applications both in vivo and in vitro.
机译:生物正交反应的出现大大拓宽了生物分子标记和检测的范围。在已开发的所有生物正交反应中,铜催化的叠氮化物-炔烃环加成反应(CuAAC)是应用最广泛的反应,主要是因为其动力学相对较快且效率很高。然而,将铜物质引入体内系统引起了潜在毒性的问题。为了减少铜诱导的毒性并进一步提高反应动力学和效率,已采用了不同的策略,包括开发各种铜螯合配体以辅助催化循环以及开发螯合叠氮化物作为试剂。到目前为止,CuAAC的优化已经促进了其在标记和鉴定特定生物分子种类或组学水平上的应用。在本文中,我们主要讨论在CuAAC的开发方面所做的努力,以更好地适应生物正交反应标准及其在体内和体外的生物正交应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号